1. Home
  2. GLP vs ANIP Comparison

GLP vs ANIP Comparison

Compare GLP & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global Partners LP

GLP

Global Partners LP

HOLD

Current Price

$49.29

Market Cap

1.6B

Sector

Energy

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$78.18

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLP
ANIP
Founded
2005
2001
Country
United States
United States
Employees
4700
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
GLP
ANIP
Price
$49.29
$78.18
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$46.00
$110.00
AVG Volume (30 Days)
43.2K
315.6K
Earning Date
05-08-2026
05-08-2026
Dividend Yield
6.40%
N/A
EPS Growth
N/A
419.23
EPS
N/A
1.28
Revenue
N/A
$206,547,000.00
Revenue This Year
$64.13
$21.01
Revenue Next Year
$11.74
$17.59
P/E Ratio
$23.28
$61.90
Revenue Growth
N/A
2.47
52 Week Low
$39.58
$56.71
52 Week High
$56.51
$99.50

Technical Indicators

Market Signals
Indicator
GLP
ANIP
Relative Strength Index (RSI) 59.86 45.10
Support Level $48.78 $77.46
Resistance Level $52.95 $83.58
Average True Range (ATR) 1.67 3.12
MACD 0.14 -0.46
Stochastic Oscillator 74.68 15.12

Price Performance

Historical Comparison
GLP
ANIP

About GLP Global Partners LP

Global Partners LP is a limited partnership that acts as a midstream logistics and marketing company. It is mainly engaged in purchasing, selling, storing and logistics of transporting petroleum and related products. The company owns and operates and control terminal networks of refined petroleum products and renewable fuels in Massachusetts, Maine, Connecticut, Vermont, and other places. It distributes gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, natural gas and propane to wholesalers, retailers and commercial customers. The company operates through three segments i.e. Wholesale, Gasoline Distribution and Station Operations and Commercial. It generates maximum revenue from the GDSO segment.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.

Share on Social Networks: